Bradsher Neal C 4

What Happened
Neal C. Bradsher, a director and reported 10% owner of STAAR Surgical Company (STAA), was granted 11,145 derivative securities (stock options) on June 18, 2026. The reported acquisition price is $0.00 per share (a grant/award), so no cash was paid by the insider in this transaction. The filing identifies the award as director compensation under the company’s Amended and Restated Omnibus Equity Incentive Plan.

Key Details

• Transaction date: June 18, 2026; Form 4 filed June 22, 2026 (filed within the typical two-business-day window).
• Instrument: 11,145 options (derivative securities) granted; reported price $0.00.
• Vesting/terms: Footnote indicates these options vest on the earlier of (a) June 18, 2027 or (b) the Issuer’s next annual meeting, subject to continuous service (F1).
• Grant origin: Issued as director compensation under the company’s equity incentive plan (F2).
• Exercisability: Filing also notes these options are currently exercisable (F3).
• Shares owned after transaction: Not specified in the provided excerpt.

Context
This was an award of equity compensation, not an open-market purchase or sale. Such grants are common for board compensation and do not by themselves indicate the insider is buying or selling stock in the market. As a reported 10% owner and director, Bradsher’s transactions are subject to Section 16 reporting rules; this filing appears timely. For derivative awards, watch vesting and exercise terms (and any subsequent exercises or sales) to understand potential future insider selling or ownership changes.